Ginkgo Bioworks (DNA) completed the first milestone of a partnership with Merck (MRK) focused on improving biologic manufacturing. As part of this milestone completion, Ginkgo will receive a research milestone payment of $9M in cash. The two companies will now move on to the second stage of this partnership, which will be focused on continuing to improve the production process.
Don't Miss out on Research Tools:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter